| Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis A Rezagholizadeh, S Khiali, P Sarbakhsh, T Entezari-Maleki European journal of pharmacology 897, 173926, 2021 | 110 | 2021 |
| A comprehensive review of tocilizumab in COVID‐19 acute respiratory distress syndrome S Khiali, E Khani, T Entezari‐Maleki The Journal of Clinical Pharmacology 60 (9), 1131-1146, 2020 | 88 | 2020 |
| SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis PS Aghbash, N Eslami, A Shamekh, T Entezari-Maleki, HB Baghi Life Sciences 270, 119124, 2021 | 74 | 2021 |
| A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis ME Hejazi, F Modarresi-Ghazani, T Entezari-Maleki Journal of research in pharmacy practice 5 (1), 7-15, 2016 | 67 | 2016 |
| A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist‐led service versus usual medical care T Entezari‐Maleki, S Dousti, H Hamishehkar, K Gholami The Journal of Clinical Pharmacology 56 (1), 24-38, 2016 | 58 | 2016 |
| Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review E Khani, S Khiali, S Beheshtirouy, T Entezari-Maleki European journal of pharmacology 912, 174582, 2021 | 56 | 2021 |
| Drug‐drug interactions with candidate medications used for COVID‐19 treatment: an overview H Rezaee, F Pourkarim, S Pourtaghi‐Anvarian, T Entezari‐Maleki, ... Pharmacology research & perspectives 9 (1), e00705, 2021 | 45 | 2021 |
| A comprehensive review on sarilumab in COVID-19 S Khiali, A Rezagholizadeh, T Entezari-Maleki Expert Opinion on Biological Therapy 21 (5), 615-626, 2021 | 42 | 2021 |
| SARS-CoV-2: receptor and co-receptor tropism probability N Eslami, PS Aghbash, A Shamekh, T Entezari-Maleki, JS Nahand, ... Current microbiology 79 (5), 133, 2022 | 41 | 2022 |
| Plasma vitamin D status and its correlation with risk factors of thrombosis, P-selectin and hs-CRP level in patients with venous thromboembolism; the first study of Iranian … T Entezari-Maleki, AH Talasaz, M Salarifar, M Hadjibabaie, MR Javadi, ... Iranian journal of pharmaceutical research: IJPR 13 (1), 319, 2014 | 39 | 2014 |
| A two-year utilization of the pharmacist-operated drug information center in Iran T Entezari-Maleki, M Taraz, MR Javadi, MH Hajimiri, K Eslami, ... Journal of research in pharmacy practice 3 (4), 117-122, 2014 | 31 | 2014 |
| Potential COVID‐19 therapeutic agents and vaccines: an evidence‐based review E Khani, S Khiali, T Entezari‐Maleki The Journal of Clinical Pharmacology 61 (4), 429-460, 2021 | 29 | 2021 |
| The effect of treatment of vitamin D deficiency on the level of P‐selectin and hs‐CRP in patients with thromboembolism: a pilot randomized clinical trial ME Hejazi, F Modarresi‐Ghazani, H Hamishehkar, M Mesgari‐Abbasi, ... The Journal of Clinical Pharmacology 57 (1), 40-47, 2017 | 29 | 2017 |
| Isotretinoin; A review on the utilization pattern in pregnancy S Khiali, A Gharekhani, T Entezari-Maleki Advanced Pharmaceutical Bulletin 8 (3), 377, 2018 | 27 | 2018 |
| Monkeypox treatment: current evidence and future perspectives E Khani, B Afsharirad, T Entezari‐Maleki Journal of medical virology 95 (1), e28229, 2023 | 25 | 2023 |
| Detection and management of common medication errors in internal medicine wards: impact on medication costs and patient care K Boostani, H Noshad, F Farnood, H Rezaee, S Teimouri, ... Advanced Pharmaceutical Bulletin 9 (1), 174, 2019 | 25 | 2019 |
| The streptokinase therapy complications and its associated risk factors in patients with acute ST elevation myocardial infarction N Aslanabadi, N Safaie, F Talebi, S Dousti, T Entezari-Maleki Iranian journal of pharmaceutical research: IJPR 17 (Suppl), 53, 2018 | 25 | 2018 |
| The role of antigen-presenting cells in the pathogenesis of COVID-19 R Farzi, PS Aghbash, N Eslami, A Azadi, A Shamekh, N Hemmat, ... Pathology-Research and Practice 233, 153848, 2022 | 21 | 2022 |
| The Effect of High-Dose Vitamin D3 on Soluble P-Selectin and hs-CRP Level in Patients With Venous Thromboembolism: A Randomized Clinical Trial K Gholami, AH Talasaz, T Entezari-Maleki, M Salarifar, M Hadjibabaie, ... Clinical and Applied Thrombosis/Hemostasis 22 (5), 483-489, 2016 | 21 | 2016 |
| Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists E Khani, T Entezari-Maleki Molecular Psychiatry 27 (9), 3562-3562, 2022 | 20 | 2022 |
Hossein Bannazadeh BaghiTabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
